| Literature DB >> 30424520 |
Zhaodi Man1, Xing Meng2, Fengxia Sun3, Yunqiu Pu4, Kai Xu5, Rongli Sun6, Juan Zhang7, Lihong Yin8, Yuepu Pu9.
Abstract
Benzene is a hematopoietic toxicant, and hematopoietic cells in bone marrow (BM) are one of the main targets for its action, especially hematopoietic stem cells (HSCs). Hypoxia-inducible factor-1α (HIF-1α) is associated with the metabolism and physiological functions of HSCs. We previously found that the mechanism of regulation of HIF-1α is involved in benzene-induced hematopoietic toxicity. In this study, chromatin immunoprecipitation sequencing (ChIP-Seq) technologies were used to analyze the genome-wide binding spectrum of HIF-1α in mouse BM cells, and specific HIF-1α target genes and pathways associated with benzene toxicity were screened and validated. By application of the ChIP-Seq technique, we identified target genes HIF-1α directly binds to and regulates. Forty-two differentially down-regulated genes containing the HIF-1α specific binding site hypoxia response element (HRE) were found, of which 25 genes were with biological function. Moreover, the enrichment analysis of signal pathways indicated that these genes were significantly enriched in the Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, the Fc epsilon RI signaling pathway, Pyrimidine metabolism, the T cell receptor signaling pathway, and Transcriptional misregulation in cancer. After verification, 11 genes involved in HSC self-renewal, cell cycle, differentiation, and apoptosis pathways were found to be significantly reduced, and may participate in benzene-induced hematotoxicity. Our study provides a new academic clue for the mechanism of benzene hematotoxicity.Entities:
Keywords: ChIP-Seq; HIF-1α; benzene; hematopoietic toxicity
Mesh:
Substances:
Year: 2018 PMID: 30424520 PMCID: PMC6266356 DOI: 10.3390/ijerph15112531
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
RT-PCR mixture.
| Reagent | Volume |
|---|---|
| DNase/RNase-Free Water | 6 μL |
| SYBR Green PCR Master mix (Toyobo) | 10 μL |
| Forward /Reverse primer (100 μM) | 0.8 μL |
| ROX Reference Dye | 0.4 μL |
| cDNA | 2 μL |
PCR primer sequences of HIF-1α target genes.
| Gene | Forward Primer | Reverse Primer |
|---|---|---|
| CTATGCTCTCCCTCACGCCA | TCACGCACGATTTCCCTCTC | |
| Ptp4a3 | CCTGTAAGGCAGCCCCAACTA | GTGTCTTAGCCAGGGTTTTATG |
| Samd4 | CAGACGAGGAAGAGTAGAGGG | ACAGACGCATTACTATCACCAA |
| Ifitm3 | GAGGACCAAGGTGCTGATGTT | TAGCCTATGCCTACTCCGTGAA |
| Gzmb | GCCAGTCTTTGCAGTCCTTTA | CTCTGATTACCCATCGTCCCT |
| Acta1 | CCTTCTGACCCATACCTACCAT | AAGCCTCACTTCCTACCCTCG |
| Rbm45 | TTTAGGTTCAGCCAAGAGTGC | CGGGAGAAGTTCAAGGTGTAT |
| Capn5 | TGATTCCTCTTAGCCTCGTCA | GTGGATTTCACAGGTGGTGTT |
| Rps3a1 | AGCAAGGCTCACTTCAAACAC | TTAGGAACATCGGGAAGACAC |
| Ipo4 | AGCCACTCCTCCATGTCTTCC | CATCTTTGGGTTGGGCGTACT |
| Asb15 | GAGCCTCAGCATAATCTCATC | TATACTTCGCCGTCTCCAATA |
| Rabgap1l | AGAGGCGGCTTAGTTGTTTGG | GCGGTCTACCTGTTGATTGCC |
Figure 1The results of chromatin immunoprecipitation sequencing (ChIP-Seq). Two samples from the low benzene (LB) group and two samples from the control group were selected. (A) Enriched peak. (B) Peak annotation. The enriched peaks were identified and classified as follows: Promoter peaks, upstream peaks, intron peaks, exon peaks, and intergenic peaks. (C) Peaks classification. Of the total generated significant peaks in the control sample (p < 0.0001), 8.17% were within the promoter region, 33.9% were within introns, and 40.84% were within the intergenic region. (D) Peak length distribution. The length distribution of the enrichment peak is calculated to infer the length of the DNA binding region. (E) ChIP-Seq peaks over chromosomes. The distribution of peaks in the genome was statistically enriched, and the chromosomes in the DNA binding region were viewed as a whole.
Sequencing reads statistics of the ChIP experiment.
| Name | Raw Reads | Mapped to Reference Genome | Mapped Percentage |
|---|---|---|---|
| C-Input | 13,294,498 | 13,049,446 | 98.16% |
| C1-IP | 16,759,284 | 16,585,336 | 98.96% |
| C2-IP | 15,330,270 | 14,798,086 | 96.53% |
| L-Input | 14,177,435 | 13,932,833 | 98.27% |
| L1-IP | 17,959,618 | 17,666,744 | 98.37% |
| L2-IP | 16,528,262 | 15,512,603 | 93.86% |
Quality control (QC) of the ChIP experiment.
| Sample Name | Size (bp) | Concentration (ng/μL) | Concentration (nmol/L) | Volume (μL) | Total Amount (ng) |
|---|---|---|---|---|---|
| C-Input | 304 | 7.98 | 39.8 | 20 | 159.6 |
| C1-IP | 336 | 9.71 | 43.7 | 20 | 194.2 |
| C2-IP | 301 | 10.02 | 50.5 | 20 | 200.4 |
| L-Input | 296 | 7.44 | 38.1 | 20 | 148.8 |
| L1-IP | 298 | 10.74 | 54.6 | 20 | 214.8 |
| L2-IP | 298 | 10.83 | 55.1 | 20 | 216.6 |
Figure 2Quality evaluation of control and LB groups by sequencing library. Two samples from the LB group and two samples from the control group were selected (L1, L2, C1, C2). (A) C-Input; (B) C1-IP; (C) C2-IP; (D) L-Input; (E) L1-IP; (F) L2-IP.
Significantly changed genes corresponding to the differentially enriched peak.
| Down-Regulated Gene Name | Fold Change | FDR | Up-Regulated Gene Name | Fold Change | FDR |
|---|---|---|---|---|---|
| Olfr1120 | −138.5 | 0.000 | Fpgt | 128.8 | 0.005 |
| Hilpda | −116.3 | 0.003 | Lrriq3 | 128.8 | 0.005 |
| Ebag9 | −116.3 | 0.003 | Pitpnm2 | 113.6 | 0.007 |
| Ptp4a3 | −105.4 | 0.002 | Rspry1 | 111 | 0.006 |
| Rgs1 | −105.4 | 0.002 | Fam192a | 111 | 0.006 |
| Tmc1 | −99.9 | 0.005 | Otud1 | 106 | 0.007 |
| Snx33 | −94.4 | 0.007 | Rab5c | 104.3 | 0.010 |
| Spred3 | −94.3 | 0.007 | Edn3 | 102.3 | 0.004 |
| Snhg17 | −94.3 | 0.007 | Ccdc88a | 97.3 | 0.007 |
| Olfr1113 | −94.3 | 0.007 | Sod2 | 96.7 | 0.012 |
| Commd9 | −89 | 0.005 | Sept9 | 96.7 | 0.012 |
| Rhno1 | −89 | 0.005 | C330013E15Rik | 96.1 | 0.012 |
| Foxm1 | −89 | 0.005 | Dynll1 | 95.5 | 0.012 |
| Pgm5 | −88.9 | 0.005 | Gm13830 | 95.5 | 0.012 |
| Mug1 | −88.8 | 0.009 | Asnsd1 | 94.1 | 0.007 |
| Samd4 | −88.8 | 0.009 | 4930486L24Rik | 90.4 | 0.012 |
Note. FDR: The corrected p-value between control (0 mg/kg, C) and benzene exposure (150 mg/kg, LB) groups.
Figure 3Gene ontology (GO) biological process classification. The pie chart shows the GO biological process (GOBP) sequencing result of genes corresponding to the reduced enrichment peak in the 150 mg/kg (LB) group compared to the control group, with the top ten counts of the significant enrichment terms.
Figure 4Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway associated with HIF-1α responsive genes. Through bioinformatics analysis, multiple pathways of HIF-1α differentially binding target genes and HIF-1α coregulated genes were obtained in mice bone marrow (BM) cells compared with the control group. The HIF-1α target genes, which correspond to the reduced enrichment peak in the 150 mg/kg (LB) group, were significantly enriched in the KEGG signaling pathway.
Pathway Results.
| Pathway | Total | Hits | Target Gene Name |
|---|---|---|---|
| Jak-STAT signaling pathway | 155 | 5 | CSF2RA, GRB2, PIK3CA, SPRED2, SPRED3 |
| Natural killer cell mediated cytotoxicity | 119 | 4 | GRB2, GZMB, LCP2, PIK3CA |
| Fc epsilon RI signaling pathway | 70 | 3 | GRB2, LCP2, PIK3CA |
| Pyrimidine metabolism | 104 | 3 | CTPS, NT5C3B, TXNRD1 |
| T cell receptor signaling pathway | 105 | 3 | GRB2, LCP2, PIK3CA |
| Transcriptional misregulation in cancer | 178 | 4 | BCL2A1C, GZMB, JMJD1C, LYL1 |
Note. Total represents the total count of the genes in the listed pathway. Hits is the actually matched enriched gene number in the pathway.
Validation of differentially deregulated genes by RT-PCR.
| Gene | 2−ΔΔ | |
|---|---|---|
| LB/C | HB/C | |
| Ptp4a3 | 0.11985 *** | 0.07554 *** |
| Samd4 | 0.10351 *** | 0.04879 *** |
| Ifitm3 | 0.39707 * | 0.53172 |
| Gzmb | 0.41548 | 0.35731 * |
| Acta1 | 0.06175 ** | 0.11185 * |
| Rbm45 | 0.70175 | 0.49878 ** |
| Capn5 | 0.08935 *** | 0.06172 *** |
| Rps3a1 | 0.48881 *** | 0.57754 ** |
| Ipo4 | 0.39123 ** | 0.31920 ** |
| Asb15 | 0.09352 ** | 0.25600 |
| Rabgap1l | 0.23461 *** | 0.41362 ** |
Note. Transcriptional level of HIF-1α target genes in mouse bone marrow cells. Eleven genes were validated in 150 mg/kg (LB) and 300 mg/kg (high benzene, HB) doses. * Significant difference compared to the control group, p < 0.05. ** Significant difference compared to the control group, p < 0.01. *** Significant difference compared to the control group, p < 0.001.